In a stunning display of loyalty that has sent shockwaves through college football, Kansas State’s five-star tight end Linkon Cure has turned down a staggering $6.7 million Name, Image, and Likeness (NIL) offer from Tennessee to remain with the Wildcats. The No. 2 tight end in the 2025 class, who signed with Kansas State in December 2024, reportedly faced intense pressure from the Volunteers to enter the transfer portal, with their offer doubling his existing NIL valuation. Cure, a Goodland, Kansas, native, stood firm, telling close associates, “I’m not for sale,” and reaffirming his commitment to Manhattan. His decision, rare in an era of lucrative NIL deals reshaping college athletics, underscores a dedication to legacy over financial temptation.
Cure, a 6-foot-6, 220-pound athletic phenom, has already made history as Kansas State’s highest-rated recruit ever, choosing the Wildcats over Oregon, Texas A&M, and Kansas last summer. His senior season at Goodland High School saw him dominate with 57 catches for 1,049 yards and 17 touchdowns, earning him a spot in the 2025 All-American Bowl. A multi-sport star with state titles in track hurdles and all-state basketball honors, Cure’s versatility and elite catch radius make him a cornerstone for coach Chris Klieman’s offense. Tennessee’s aggressive pursuit, reportedly leveraging their robust NIL collective, aimed to pair Cure with their dynamic quarterback Nico Iamaleava, but Cure’s deep ties to Kansas State—where he grew up attending games and idolizing players like Collin Klein—proved unshakable.
The decision comes amid growing scrutiny of NIL’s impact on college football, with programs like Tennessee, Alabama, and Texas using multimillion-dollar deals to attract top talent. Cure’s choice to stay, despite an offer that could have set a new benchmark for tight ends, highlights Kansas State’s unique culture under Klieman, who has prioritized in-state talent like quarterback Avery Johnson and running back Dylan Edwards. Sources close to Cure indicate his emotional connection to Manhattan, where he made his commitment decision in Section 227 of Bill Snyder Family Stadium, played a pivotal role. His rejection of Tennessee’s offer, described as one of the largest ever for a freshman, has sparked widespread praise from Wildcat fans and analysts, who see Cure as a symbol of loyalty in a mercenary era.
As Kansas State prepares for the 2025 season, Cure’s commitment strengthens a program aiming for a Big 12 title and a College Football Playoff berth. His skill set, blending wide receiver agility with tight end physicality, is expected to make an immediate impact alongside Johnson, potentially replicating the success of former K-State tight end Ben Sinnott, a 2024 NFL Draft pick. While Cure’s blocking skills need refinement, his high-point catches and track-star speed make him a matchup nightmare. By choosing Kansas State over Tennessee’s millions, Cure has not only solidified his status as a Wildcat warrior but also ignited a broader conversation about values, loyalty, and the future of college football in the NIL era.
